Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1-T2 HPV Negative oropharyngeal squamous cell carcinoma.
Francisco LaxagueNaif FnaisHee Young SonFaisal AlzahraniJoe S MymrykJohn W BarrettKeng Yow TayAndrew LeungJulie TheurerAnthony Charles NicholsDavid A PalmaPublished in: Head & neck (2024)
Patients with TOS-favorable HPV-negative early T-stage OPSCC have superior survival outcomes than TOS-unfavorable patients.